
Sign up to save your podcasts
Or


Integral Ad Science has evolved from a brand safety purveyor to a holistic arbiter of ad quality. What's next? In this episode, Knoll talks about the IAS product roadmap, and suggests the ability to track duration of ad exposure across media placements represents a new direction. He also discusses the company's financials and the possibility of a 2017 IPO.
By AdExchanger Talks4.5
7171 ratings
Integral Ad Science has evolved from a brand safety purveyor to a holistic arbiter of ad quality. What's next? In this episode, Knoll talks about the IAS product roadmap, and suggests the ability to track duration of ad exposure across media placements represents a new direction. He also discusses the company's financials and the possibility of a 2017 IPO.

9,576 Listeners

1,100 Listeners

559 Listeners

103 Listeners

1,484 Listeners

45 Listeners

349 Listeners

3,002 Listeners

5,533 Listeners

9,901 Listeners

5,472 Listeners

353 Listeners

1,088 Listeners

22 Listeners

33 Listeners